Compugen Ltd.
(TEL Aviv Stock Exchange : CGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 6.26%221.270.0%$1938.34m
BIIBBiogen, Inc. -2.47%371.501.7%$1302.01m
SNSSSunesis Pharmaceuticals, Inc. -8.81%11.690.7%$817.17m
NVAXNovavax, Inc. 7.56%194.6879.8%$807.42m
AMGNAmgen, Inc. -0.35%239.411.3%$661.17m
BNTXBioNTech SE 4.25%235.700.0%$576.45m
VRTXVertex Pharmaceuticals, Inc. 0.34%188.341.9%$535.92m
GILDGilead Sciences, Inc. -0.68%66.901.0%$494.68m
REGNRegeneron Pharmaceuticals, Inc. -0.31%532.602.7%$387.20m
ILMNIllumina, Inc. 0.55%463.573.5%$351.28m
ALXNAlexion Pharmaceuticals, Inc. -0.71%179.382.0%$337.51m
OCGNOcugen, Inc. -4.20%7.090.0%$328.32m
TXG10X Genomics, Inc. 0.02%197.910.0%$177.37m
EXASEXACT Sciences Corp. 0.37%128.1318.1%$177.05m
TECHBio-Techne Corp. 0.15%440.864.5%$164.08m

Company Profile

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.